2021
DOI: 10.3389/fonc.2021.708655
|View full text |Cite
|
Sign up to set email alerts
|

MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier

Abstract: ObjectiveTo develop a machine learning (ML)-based classifier for discriminating between low-grade (ISUP I-II) and high-grade (ISUP III-IV) clear cell renal cell carcinomas (ccRCCs) using MRI textures.Materials and MethodsWe retrospectively evaluated a total of 99 patients (with 61 low-grade and 38 high-grade ccRCCs), who were randomly divided into a training set (n = 70) and a validation set (n = 29). Regions of interest (ROIs) of all tumors were manually drawn three times by a radiologist at the maximum lesio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(5 citation statements)
references
References 27 publications
0
0
0
Order By: Relevance
“…Chen et al [41] aimed at grading ccRCC using Phase 2 CEMRI. Their study included 99 tumors, with 61 low-grade and 38 high-grade cases.…”
Section: Magnetic Resonance Imaging (Mri) Studiesmentioning
confidence: 99%
See 4 more Smart Citations
“…Chen et al [41] aimed at grading ccRCC using Phase 2 CEMRI. Their study included 99 tumors, with 61 low-grade and 38 high-grade cases.…”
Section: Magnetic Resonance Imaging (Mri) Studiesmentioning
confidence: 99%
“…This survey reviews the studies from the previous decade that used AI and radiomicbased markers derived from CECT, CEMR, multiparametric MR, or DW-MR imaging modalities to produce AI-based CAD systems for diagnosing RC at an early stage. Specifically, the included studies aimed to identify a given renal tumor malignancy status [14,[27][28][29][30][31][32][33], specify the associated subtype [22,[33][34][35][36], and grade/stage the malignant tumors (I-IV) [22,[37][38][39][40][41]. In addition to accurate diagnosis, treatment follow-up protocol is crucial to evaluate patients' clinical outcome/treatment response, including the recurrence rate, overall survival (OS), and progression-free survival (PFS) rate.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations